BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 20142449)

  • 1. Th17 and Th1 T-cell responses in giant cell arteritis.
    Deng J; Younge BR; Olshen RA; Goronzy JJ; Weyand CM
    Circulation; 2010 Feb; 121(7):906-15. PubMed ID: 20142449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
    Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
    Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis.
    Weyand CM; Younge BR; Goronzy JJ
    Curr Opin Rheumatol; 2011 Jan; 23(1):43-9. PubMed ID: 20827207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and Function of IL12/23 Related Cytokine Subunits (p35, p40, and p19) in Giant-Cell Arteritis Lesions: Contribution of p40 to Th1- and Th17-Mediated Inflammatory Pathways.
    Espígol-Frigolé G; Planas-Rigol E; Lozano E; Corbera-Bellalta M; Terrades-García N; Prieto-González S; García-Martínez A; Hernández-Rodríguez J; Grau JM; Cid MC
    Front Immunol; 2018; 9():809. PubMed ID: 29731755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.
    Terrier B; Geri G; Chaara W; Allenbach Y; Rosenzwajg M; Costedoat-Chalumeau N; Fouret P; Musset L; Benveniste O; Six A; Klatzmann D; Saadoun D; Cacoub P
    Arthritis Rheum; 2012 Jun; 64(6):2001-11. PubMed ID: 22147555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of giant cell arteritis: new insight into the implication of CD161+ T cells.
    Samson M; Audia S; Martin L; Janikashvili N; Bonnotte B
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S65-73. PubMed ID: 23663684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1 and Th17 lymphocytes expressing CD161 are implicated in giant cell arteritis and polymyalgia rheumatica pathogenesis.
    Samson M; Audia S; Fraszczak J; Trad M; Ornetti P; Lakomy D; Ciudad M; Leguy V; Berthier S; Vinit J; Manckoundia P; Maillefert JF; Besancenot JF; Aho-Glele S; Olsson NO; Lorcerie B; Guillevin L; Mouthon L; Saas P; Bateman A; Martin L; Janikashvili N; Larmonier N; Bonnotte B
    Arthritis Rheum; 2012 Nov; 64(11):3788-98. PubMed ID: 22833233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
    Brack A; Rittner HL; Younge BR; Kaltschmidt C; Weyand CM; Goronzy JJ
    J Clin Invest; 1997 Jun; 99(12):2842-50. PubMed ID: 9185506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell vasculitis is a T cell-dependent disease.
    Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
    Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of acetylsalicylic acid in giant cell arteritis.
    Weyand CM; Kaiser M; Yang H; Younge B; Goronzy JJ
    Arthritis Rheum; 2002 Feb; 46(2):457-66. PubMed ID: 11840449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis.
    Piggott K; Deng J; Warrington K; Younge B; Kubo JT; Desai M; Goronzy JJ; Weyand CM
    Circulation; 2011 Jan; 123(3):309-18. PubMed ID: 21220737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis.
    Ciccia F; Rizzo A; Guggino G; Cavazza A; Alessandro R; Maugeri R; Cannizzaro A; Boiardi L; Iacopino DG; Salvarani C; Triolo G
    Rheumatology (Oxford); 2015 Sep; 54(9):1596-604. PubMed ID: 25862016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis.
    Espígol-Frigolé G; Corbera-Bellalta M; Planas-Rigol E; Lozano E; Segarra M; García-Martínez A; Prieto-González S; Hernández-Rodríguez J; Grau JM; Rahman MU; Cid MC
    Ann Rheum Dis; 2013 Sep; 72(9):1481-7. PubMed ID: 22993227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MMP (Matrix Metalloprotease)-9-Producing Monocytes Enable T Cells to Invade the Vessel Wall and Cause Vasculitis.
    Watanabe R; Maeda T; Zhang H; Berry GJ; Zeisbrich M; Brockett R; Greenstein AE; Tian L; Goronzy JJ; Weyand CM
    Circ Res; 2018 Aug; 123(6):700-715. PubMed ID: 29970365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neointimal myofibroblasts contribute to maintaining Th1/Tc1 and Th17/Tc17 inflammation in giant cell arteritis.
    Greigert H; Ramon A; Genet C; Cladière C; Gerard C; Cuidad M; Corbera-Bellalta M; Alba-Rovira R; Arnould L; Creuzot-Garcher C; Martin L; Tarris G; Ghesquière T; Ouandji S; Audia S; Cid MC; Bonnotte B; Samson M
    J Autoimmun; 2024 Jan; 142():103151. PubMed ID: 38039746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpin treatment suppresses inflammatory vascular lesions in temporal artery implants (TAI) from patients with giant cell arteritis.
    Chen H; Zheng D; Ambadapadi S; Davids J; Ryden S; Samy H; Bartee M; Sobel E; Dai E; Liu L; Macaulay C; Yachnis A; Weyand C; Thoburn R; Lucas A
    PLoS One; 2015; 10(2):e0115482. PubMed ID: 25658487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis.
    Conway R; O'Neill L; McCarthy GM; Murphy CC; Fabre A; Kennedy S; Veale DJ; Wade SM; Fearon U; Molloy ES
    Ann Rheum Dis; 2018 Dec; 77(12):1815-1824. PubMed ID: 30097452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic approach to giant cell arteritis.
    Masson C
    Joint Bone Spine; 2012 May; 79(3):219-27. PubMed ID: 22119350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation analysis of the temporal artery microenvironment in giant cell arteritis.
    Coit P; De Lott LB; Nan B; Elner VM; Sawalha AH
    Ann Rheum Dis; 2016 Jun; 75(6):1196-202. PubMed ID: 26038090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.